Navigation Links
ePharmaSolutions Launches Major Release of Its Global Safety Letter Distribution and Tracking Application in More Than 90 Countries

CONSHOHOCKEN, Pa., April 13, 2011 /PRNewswire/ -- At the World Drug Safety Congress in Boston, MA, ePharmaSolutions announced a major release of its global safety letter distribution system to support the most recent national and local regulations while offering sponsors a more simplified workflow with advanced distribution and tracking capabilities.

The distribution and tracking of safety letters has been an expensive and time consuming process for global biopharmaceutical companies who are required to remain in strict compliance with national and local regulations while reducing overall trial cost.  As regulatory bodies increase their requirements for timely distribution of safety information during and after clinical trials are conducted, pharmaceutical companies are pressured to comply and need cost effective solutions to support the global enterprise.

"Tracking the distribution of safety letters has typically been a manual process that is delivered by overnight courier, fax or email and requires significant logistical preparation to ensure the right sites receive the right safety letters at the right time," stated Dave Espenshade, ePharmaSolutions' Senior Vice President of Sales.  "However most of these methods cannot ensure the right users actually received and read the notification, and none of them support all of the current regulations at the national and local level," added Espenshade.

ePharmaSolutions' latest release includes a full integration with the leading CTMS vendors in real time, automatically generating distribution lists using sophisticated algorithms that operate at region, country, compound, study, site and EC/IRB levels, and eliminating any room for error.  In addition, the system integrates with leading drug safety systems and distributes notifications via email, fax or courier providing a central repository for reporting – regardless of the distribution method.  The Safety Letter Distribution system supports all types of safety letters including blinded, unblinded and open label distributions, IBs, Addendums and Core Data Sheets, 7 and 15 day SUSARs, ASRs, SSRs, and DSURs.

"This release provides our clients with the most comprehensive and compliant solution currently available and can be rapidly deployed at the enterprise or project/compound level using our fully validated cloud based model," added Lance Converse, ePharmaSolutions Founder and CEO.

Philip Ditoro, Esq. of ePharmaSolutions will be presenting a demonstration of the Safety Letter Distribution and Tracking system along with lessons learned Q&A regarding global deployment of this enterprise solution at the World Drug Safety Congress in Boston, MA on April 13th, 2011.

About ePharmaSolutions

ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.   ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 220,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in London. For more information visit or call Lance Converse at 610-832-9915.  Follow us on LinkedIn and Facebook.

SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):